Haiti Community Health Workers (CHW) Adaptation
Pilot Trial of a Community Health Worker Intervention to Improve Heart Failure Care in Rural Haiti
2 other identifiers
interventional
30
1 country
1
Brief Summary
Evidence-based interventions to improve linkage and outcomes for heart failure (HF) patients requires input from stakeholders: patients, community health workers (CHWs), healthcare staff, and health system administrators. In this research the investigators will assess a CHW intervention designed to improve linkage to care for HF patients. This intervention was systematically adapted for use in rural Haiti in a prior study using the Assessment, Decisions, Administration, Production, Topical Experts, Integration, Training staff, Testing (ADAPT-ITT) framework. The ADAPT-ITT framework provides 8 sequential phases to adapt interventions and programs to new target audiences. It has been applied successfully to the adaptation of several interventions for HIV among under-resourced communities leading to randomized clinical trials. With the first 6 steps of the ADAPT-ITT framework completed in a prior study, this protocol outlines the training and testing of the adapted CHW intervention. In addition to assessing the feasibility, appropriateness, and acceptability of the adapted intervention through participants' feedback, the investigators will assess its efficacy in improving HF outcomes. The proposed intervention is targeted at both the patient domain - through improved peer support - and health system domain - by improving health system navigation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Feb 2023
Typical duration for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2021
CompletedFirst Posted
Study publicly available on registry
October 25, 2021
CompletedStudy Start
First participant enrolled
February 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedNovember 10, 2025
November 1, 2025
2.5 years
September 15, 2021
November 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Acceptability of HF follow up program to patients
Acceptability of the HF follow up program to patients will be assessed using a 5-point Likert scale response to the question "Was it acceptable to have a CHW come to your home to educate you in your heart failure care and encourage clinic follow-up?" where 1=not acceptable, 5=very acceptable.
90 days
Acceptability of HF follow up program to Community Health Workers (CHWs)
Acceptability of the HF follow up program to CHWs will be assessed using a 5-point Likert scale response to the question "Was it acceptable to have a CHW come to your home to educate you in your heart failure care and encourage clinic follow-up?" where 1=not acceptable, 5=very acceptable.
12 months
Acceptability of HF follow up program to nurses/doctors
Acceptability of the HF follow up program to nurses/doctors will be assessed using a 5-point Likert scale response to the question "Was it acceptable to have a CHW come to your home to educate you in your heart failure care and encourage clinic follow-up?" where 1=not acceptable, 5=very acceptable.
12 months
Appropriateness of HF follow up program to patients
Appropriateness of HF follow up program to patients will be assessed using a 5-point Likert scale response to the question "Were you satisfied with the CHWs interactions with you?" where 1=not acceptable, 5=very acceptable.
90 days
Appropriateness of HF follow up program to CHWs
Appropriateness of HF follow up program to CHWs will be assessed using a 5-point Likert scale response to the question "Were you satisfied with the CHWs interactions with you?" where 1=not acceptable, 5=very acceptable.
12 months
Appropriateness of HF follow up program to nurses/doctors
Appropriateness of HF follow up program to nurses/doctors will be assessed using a 5-point Likert scale response to the question "Were you satisfied with the CHWs interactions with you?" where 1=not acceptable, 5=very acceptable.
12 months
Feasibility of HF follow up program to patients
Feasibility of HF follow up program to patients will be assessed by the percent of invited eligible patients who consent to participate. The higher the percentage of consenting patients, the more feasible the program.
90 days
Feasibility of HF follow up program to CHWs
Feasibility of HF follow up program to CHWs will be assessed by the percent of invited CHWs who complete the training. The higher the percentage, the more feasible the program.
90 days
Fidelity of HF follow up program
Fidelity of HF follow up program will be assessed by the percent of home visit checklist items completed by CHWs. The higher the percentage, the greater the fidelity.
90 days
HF follow up program intervention components delivered
Assessed by the number of interventions delivered based abstracted from the home visit checklist completed by the CHWs.
90 days
Completion of scheduled visits
Assessed by the percent of scheduled visits that were completed from the CHW records.
90 days
Percent of visits with all home visit checklist items completed
Assessed by dividing the number of visits with all home visit checklist items completed by the total number of visits.
90 days
Secondary Outcomes (7)
Linkage of HF patients
30 days
Retention of HF patients
90 days
Hospital readmission rate
90 days
Patient symptoms based on the New York Heart Association (NYHA) Classification
90 days
Patient quality of life assessed European Quality of Life 5D (EuroQol 5D)
30 days, 90 days
- +2 more secondary outcomes
Study Arms (2)
Follow up care program for HF patients
EXPERIMENTALDischarged HF patients in rural Haiti will be receive a follow-up care program delivered by trained community health workers (CHWs).
Standard of care
OTHERHistorical reference group who received standard of care for HF identified prior to CHW training.
Interventions
The intervention will consist of follow up phone calls and visits during which the CHWs will remind patients about upcoming visits, ensure patient has sufficient medications, review medication schedule and provide education as needed.
SOC after discharge for HF is to notify patients of a follow-up visit at the hospital/clinic - about 7 days after discharge and provide patients about 30 days of medications at discharge. If a patient does not return for a follow-up appointment, there are no systems to track this missed visit, or to trigger active attempts to contact patients. For patients who come back to their scheduled 7-day visit, there is generally a 14-day visit followed by a 28-day visit.
Eligibility Criteria
You may qualify if:
- Adult HF patients
- Hospitalized \>48 hours at Hôpital-Universitaire de Mirebalais (HUM)
- Anticipated discharge from HUM within 1-3 days
- Adult HF patients
- Hospitalized \>48 hours at HUM
- Discharged from HUM within the 12 months preceding the intervention
- Living in Mirebalais Commune
You may not qualify if:
- None
- Adult
- Provide inpatient or outpatient care to HF patients
- Working in in Mirebalais
- None
- Hospital leadership involved in supervision of clinical care programs (i.e. Chief Executive Officer, Chief Medical Officer, Chief Operations Officer, Chief Nursing Officer, etc.)
- Leaders of the Community Health Department - including the nurse Director of Community Health, and Community Health Worker Supervisors.
- Healthcare providers at HUM involved in the care of patients with heart failure (i.e. internal medicine physicians, inpatient hospital nurses, outpatient clinic physicians, outpatient clinic nurses, etc.)
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zanmi Lasante/Hôpital Universitaire de Mirebalais
Mirebalais, Haiti
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gene F Kwan, MD MPH
Boston Medical Center, Cardiovascular Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2021
First Posted
October 25, 2021
Study Start
February 23, 2023
Primary Completion
August 31, 2025
Study Completion
August 31, 2025
Last Updated
November 10, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share